I fully agree Terryz. Im sure they must already be in some discussion with a Big Pharma or two on a deal that would encompass the entire vaccine program that rolls out from the Prof Frazer breakthrough in DNA vaccinnes.
Their confidence in the HSV2 vaccinne appears very high and thus I think they will await at least startling preliminary results from the phase 2 trial before finalising any partner deal ....the delay until then thus placing admedus in a stronger bargaining position.
Fox
Nice finish, page-49
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.00 |
Change
0.150(1.01%) |
Mkt cap ! $317.0M | |||
| Open | High | Low | Value | Volume |
| $15.00 | $15.15 | $14.30 | $210.2K | 14.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $14.60 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.00 | 5153 | 3 |
View Market Depth
| Last trade - 16.10pm 14/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |